• No products in the cart.
  • News
  • MyCELLINK
  • Support
  • Contact us
  • Language
    • English
    • 中文
    • 日本語
    • 대한민국
  • No products in the cart.
  • Bioprinters
    • Overview
    • Extrusion-based
      • BIO X™
      • BIO X6™
      • INKREDIBLE+™
      • Software
        • DNA Studio 4
        • DNA Studio 4 Vault
    • Light-based
      • BIONOVA X
      • Quantum X bio
      • Lumen X+
    • Biodispenser
      • BIO CELLX
    • Bioprinting Protocols
  • Biomaterials
    • Overview
    • Bioinks
    • Bioink components
    • Ready-to-use bioinks
    • Tissue-specific bioinks
    • Other
    • Bioink accessories
    • Bioprinting Protocols
  • Resources
    • Overview
    • Events
      • Webinars
    • Areas of impact
      • Overview
      • Cell-cultured Meat
      • Drug Discovery
      • Personalized Medicine
      • Regenerative Medicine
    • Application notes
    • Publications
    • Protocols
    • Blog
    • Customer spotlights
    • Research projects
      • Grants
  • Success Stories
  • Company
    • About CELLINK
    • Careers
    • Sustainability
      • Overview
      • Sustainable Tissue Engineering Practices
    • Contact us
    • Support
    • News
  • Shop
  • Get a quote
  • Bioprinters
    • Overview
    • Extrusion-based
      • BIO X™
      • BIO X6™
      • INKREDIBLE+™
      • Software
        • DNA Studio 4
        • DNA Studio 4 Vault
    • Light-based
      • BIONOVA X
      • Quantum X bio
      • Lumen X+
    • Biodispenser
      • BIO CELLX
    • Bioprinting Protocols
  • Biomaterials
    • Overview
    • Bioinks
    • Bioink components
    • Ready-to-use bioinks
    • Tissue-specific bioinks
    • Other
    • Bioink accessories
    • Bioprinting Protocols
  • Resources
    • Overview
    • Events
      • Webinars
    • Areas of impact
      • Overview
      • Cell-cultured Meat
      • Drug Discovery
      • Personalized Medicine
      • Regenerative Medicine
    • Application notes
    • Publications
    • Protocols
    • Blog
    • Customer spotlights
    • Research projects
      • Grants
  • Success Stories
  • Company
    • About CELLINK
    • Careers
    • Sustainability
      • Overview
      • Sustainable Tissue Engineering Practices
    • Contact us
    • Support
    • News
  • Shop

  • News
  • MyCELLINK
  • Support
  • Contact us
  • Sustainability
  • Get a quote

Company News and Press Releases

  • All news
  • 3d bioprinting
  • Bioink
  • Biotech
  • Company news
  • Group news
  • Industry News
February 27, 2023 | Company news

CELLINK and Nanyang Technological University jointly open a Research, Innovation and Development Lab focused on exploring bioprinting in critical use cases like regenerative medicine and drug discovery.

February 14, 2023 | Company news

CELLINK Introduces DNA Studio 4 Vault, a bioprinting software developed to support our customers to adhere to Title 21 CFR Part 11 Electronic records and EudraLex – Volume 4 – Good Manufacturing Practice (GMP) guidelines – Chapter 4: Documentation

December 9, 2022 | Company news

CELLINK and the Indian Institute of Science inaugurate first Centre of Excellence for 3D Bioprinting in India

September 13, 2022 | Company news

CELLINK is awarded Göteborgs Companipris

July 4, 2022 | Company news

CELLINK has entered a collaboration agreement with Spermosens AB, Malmö University and SLU to develop an invitro diagnostic (IVD) device that helps determine infertility.

May 6, 2022 | Company news

BICO acquires Allegro 3D, adding new light-based 3D bioprinting technology

May 5, 2022 | Company news

CELLINK Announces CTR Scientific as Exclusive Distributor in Mexico

April 21, 2022 | Company news

CELLINK Enters a Collaboration Agreement with Zoan BioMed to Develop Bioinks for Bone Regeneration and Coral Restoration

April 18, 2022 | Company news

CELLINK Inaugurates Good Manufacturing Practice (GMP) Lab at Their Kallebäck Location to Enable Clinical Grade Bioinks for Human Applications.

March 1, 2022 | Company news

Launching the BIO CELLX

February 16, 2022 | Company news

Upscaling production of CollPlant’s regenerative breast implants using our bioprinting technologies

December 15, 2021 | Company news

CELLINK and Nanoscribe join forces to launch the Quantum X bio

October 14, 2021 | Company news

BICO strengthens IP portfolio with two additional patents for 3D bioprinting

April 14, 2021 | Company news

CELLINK receives the prestigious gold award for the BIO X6 at the iF Design Awards 2021

March 23, 2021 | Company news

BIO X6 wins prestigious Red Dot Design Award for outstanding design quality

January 28, 2021 | Company news

CELLINK announces third year extension of collaboration with a global biopharmaceutical company for drug discovery

November 11, 2020 | Company news

CELLINK will help develop 3D bioprinted personalised scaffolds for tissue regeneration of ankle joint s as part of the TRIANKLE project

August 14, 2020 | Company news

Partnership with Carcinotech to advance 3D-bioprinting technology for cancer research

July 21, 2020 | Company news

CELLINK and Kugelmeiers Ltd. announce strategic partnership for 3D printing cell spheroids

May 14, 2020 | Company news

CELLINK announces collaboration with AstraZeneca to utilize CELLINK’s 3D-bioprinting technology for liver organoid culture

October 1, 2019 | Company news

CELLINK granted design patent for BIO X

September 27, 2019 | Company news

CELLINK’s New Bioprinting Platform for Complex Structures, the BIO X6

September 3, 2019 | Company news

CELLINK announces a new product, the BIO X6

July 12, 2019 | Company news

CELLINK granted Korean patent for ‘Clean Chamber’ bioprinting technology

July 2, 2019 | Company news

CELLINK and Uppsala University Send Stem Cells to Space

June 26, 2019 | Company news

CELLINK sends bioprinted neural crest stem cells to space

June 14, 2019 | Company news

Terralab as CELLINK’s Turkey Distributor Partner

May 2, 2019 | Company news

CELLINK launches new tissue model kits

March 22, 2019 | Company news

CELLINK and the Adult Stem Cell Research Center at Seoul National University announce new agreement for bioprinting research

December 4, 2018 | Company news

CELLINK announces collaboration with MedImmune

November 8, 2018 | Company news

CELLINK presents new bioink series

October 18, 2018 | Company news

CELLINK is launching new bioinks

October 8, 2018 | Company news

CELLINK Releases Game Changer Inkjet Printhead

August 28, 2018 | Company news

CELLINK proudly presents the LAMININ-SERIES in collaboration with BIOLAMINA Laminins are proteins composed of three subunits referred to as a α-chain, β-chain and γ-chain. They are a major component of the basal lamina that lines the external surface of cell membranes. This protein is characterized by its cross-like structure that serves as a structural foundation for […]

CELLINK is launching a new bioink series

June 1, 2018 | Company news

CELLINK Collaborator Work Featured in Tech Crunch: 3D Printed Corneas

April 12, 2018 | Company news

CELLINK Releases 7 New Bioinks, 3 New Kits that Standardize GelMA and Enable the Bioprinting of Multifaceted Vascularized Constructs such as Skin

April 9, 2018 | Company news

CELLINK wins prestigious Red Dot Award for the innovative BIO X bioprinter

February 1, 2018 | Company news

CELLINK opens office at Kyoto University in Japan

January 8, 2018 | Company news

CTIBIOTECH are leading a new path towards personalized cancer therapies through utilization of CELLINK’s technology platform. By taking a small piece of a patient’s tumor, multiplying the cells, and then bioprinting the patient’s tumor in the laboratory, researchers can discover, understand and find the exact treatment best for the specific cancer. CTIBIOTECH uses 3D bioprinting […]

CELLINK signs collaboration agreement with CTIBIOTECH for Bioprinting of patient-specific cancer tumors

November 27, 2017 | Company news

CELLINK AB has been granted project funding from Horizon 2020

November 15, 2017 | Company news

CELLINK enters a collaborative research program with Takara Bio

October 3, 2017 | Company news

CELLINK is happy to announce the CELLINK 3D Bioprinting Award for students and young scientists who present innovative 3D Bioprinting solutions at the 2017 TERMIS-AM conference in Charlotte, NC, USA. The award will be provided to a student or young investigator that is presenting his/her work based on an innovative 3D Bioprinting solution.  Representatives from […]

CELLINK 3D Bioprinting Award to be Presented at TERMIS-AM

Logotype_RGB_Cellink_Neg.png
Keep up with the latest bioprinting news by signing up for our emails
Subscribe

Contact us

Send us an email by filling in the contact form here. 

U.S.: +1 (833) 235-5465
EU: +46 31-12 87 00
India: +91 (0) 98808 58741
Japan: +81 (75)746-3032
Singapore: +65 8750 2284

Navigation

About us
Careers
Sustainability
MyCELLINK
3D bioprinters
Biomaterials
Shop

Policies

Supplier Code of Conduct
Internal Code of Conduct
Whistleblower/Speak-up channel
Quality Policy

CELLINK is a part of BICO. Our products aim to reduce the organ shortage and speed up drug development by providing accessible life science solutions that combine biology and technology, fundamentally shifting the global healthcare industry.

Read more at BICO.com
  • Cookie Policy
  • Privacy Policy
  • Report a Cyber Security Incident
Menu
  • Cookie Policy
  • Privacy Policy
  • Report a Cyber Security Incident
Linkedin Instagram Facebook Twitter Youtube
Copyright © 2023 CELLINK - All rights reserved.